Latest Insider Transactions at Minerva Surgical Inc (UTRS)
This section provides a real-time view of insider transactions for Minerva Surgical Inc (UTRS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MINERVA SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MINERVA SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2023
|
New Enterprise Associates 13 LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
24,437,927
+41.51%
|
$0
$0.2 P/Share
|
|
Jul 19
2022
|
Derrick Sung Director |
BUY
Grant, award, or other acquisition
|
Direct |
86,956
+50.0%
|
$173,912
$2.3 P/Share
|
|
Jun 10
2022
|
Jill Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,792
+50.0%
|
$99,584
$2.41 P/Share
|
|
Jun 10
2022
|
Catherine Coste Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,792
+27.76%
|
$99,584
$2.41 P/Share
|
|
Jun 10
2022
|
Niquette L. Hunt Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,792
+50.0%
|
$99,584
$2.41 P/Share
|
|
Jun 10
2022
|
David Renzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,792
+50.0%
|
$99,584
$2.41 P/Share
|
|
Jun 10
2022
|
Ross A Md Jaffe Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,792
+50.0%
|
$99,584
$2.41 P/Share
|
|
Jun 10
2022
|
Ali Behbahani Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,792
+46.07%
|
$99,584
$2.41 P/Share
|
|
May 02
2022
|
David M Clapper President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
229,732
+41.55%
|
-
|
|
May 02
2022
|
Joel R Jung CFO |
BUY
Grant, award, or other acquisition
|
Direct |
60,198
+21.43%
|
-
|
|
May 02
2022
|
Dominique J. Filloux COO |
BUY
Grant, award, or other acquisition
|
Direct |
60,198
+18.44%
|
-
|
|
May 02
2022
|
Evgueni V. Skalnyi VP Medical Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
49,755
+16.9%
|
-
|
|
Dec 15
2021
|
David M Clapper President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
93,500
+50.0%
|
-
|
|
Dec 15
2021
|
Dominique J. Filloux COO |
BUY
Grant, award, or other acquisition
|
Direct |
24,500
+10.62%
|
-
|
|
Dec 15
2021
|
Joel R Jung CFO |
BUY
Grant, award, or other acquisition
|
Direct |
24,500
+13.24%
|
-
|
|
Dec 15
2021
|
Evgueni V. Skalnyi VP Medical Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
20,250
+9.41%
|
-
|
|
Dec 13
2021
|
David M Clapper President and CEO |
BUY
Open market or private purchase
|
Indirect |
25,000
+3.74%
|
$100,000
$4.94 P/Share
|
|
Oct 26
2021
|
Ross A Md Jaffe Director |
BUY
Conversion of derivative security
|
Indirect |
94,755
+50.0%
|
-
|
|
Oct 26
2021
|
New Enterprise Associates 13 LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,300,000
+11.51%
|
$15,600,000
$12.0 P/Share
|
|
Oct 26
2021
|
New Enterprise Associates 13 LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
8,699,125
+39.58%
|
-
|
|
Oct 26
2021
|
Ali Behbahani Director |
BUY
Conversion of derivative security
|
Direct |
8,487
+41.12%
|
-
|
|
Oct 26
2021
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
580,000
+21.99%
|
$6,960,000
$12.0 P/Share
|
|
Oct 26
2021
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,477,132
+39.32%
|
-
|